A weight-management website can describe the beginning of a care relationship without showing how the rest works. That is the central distinction at slimshot.net, whose terms identify the operator as NOVA HEALTH PEPTIDES LLC ARIEL GUTIERREZ SOLE MBR. The consulted sources do not confirm a GLP-1 program. Instead, they present a medical weight-management practice offering assessment, personalized recommendations, nutrition education and follow-up. Neither the domain name nor “PEPTIDES” in the company name establishes which medicines, if any, the practice offers.
This review follows the documented patient pathway: making contact, establishing who provides care, completing an assessment, understanding the proposed plan and arranging ongoing support. The public documentation consulted October 19, 2026 gives useful detail about those early steps, but does not identify a medication, dispensing pharmacy or delivery process. It also contains unfinished and conflicting legal language. For prospective patients, the practical task is to obtain a complete, current service description before treating this website as a verified medication-based weight-loss program.
At a glance
- GLP-1 status
- The consulted sources do not confirm a GLP-1 program or identify a medicine, formulation, route or dispensing pharmacy.Sources: [1]
- Documented operator
- The terms name NOVA HEALTH PEPTIDES LLC ARIEL GUTIERREZ SOLE MBR as the website owner and operator; the d/b/a field is blank.Sources: [3]
- Care described
- The website advertises physician assessment, individualized recommendations, metabolic-health review, lifestyle guidance and follow-up.Sources: [1]
- Remote access
- Telehealth may be available only for eligible patients when clinically appropriate and permitted by applicable regulations; no state-by-state availability list is established.Sources: [1]
The care pathway starts with an inquiry, not a documented prescription offer
The website invites prospective patients to contact the practice by phone or email to ask about consultation availability and next steps. Its published telephone number is +1 941-250-4470. That is a concrete access point, but not a documented promise of an appointment, clinical acceptance or prescription. The email address appears obscured in the consulted material, so it is not a dependable contact detail to reproduce. No confirmed patient portal or specific support hours are established.
The footer mentions Sarasota, Florida, but that reference does not establish a consultation address or the states where patients can receive care. Telehealth is presented conditionally: appointments may be available for eligible patients when appropriate clinically and permitted by applicable regulations. Someone outside Sarasota should therefore establish whether the practice can serve their location before paying or sending extensive health information. A Florida reference alone is not a national coverage map.
The first call should resolve the basics: where the appointment occurs, whether it is remote or in person, who conducts it and what happens afterward. Our overview of the care journey from intake to follow-up provides a framework for organizing those questions, not evidence that this practice supplies every step. Here, the public pathway begins with an invitation to inquire rather than a fully specified enrollment and treatment process.
| Care stage | Publicly described | Confirm before proceeding |
|---|---|---|
| Initial contact | Telephone inquiry about availability and next steps | Appointment format, location and initial fee |
| Clinical assessment | History, prior weight-loss efforts and clinical goals | Treating clinician, required records and any testing |
| Care plan | Individualized recommendations and possible lifestyle support | Exact services, any medication and separate charges |
| Pharmacy handoff | No pharmacy or medicine identified | Whether prescribing occurs and who dispenses |
| Follow-up | Monitoring cadence recommended by the physician | Visit schedule, contact route and follow-up costs |
Identify the treating professional before relying on the platform description
The terms identify the website owner and operator using the full name NOVA HEALTH PEPTIDES LLC ARIEL GUTIERREZ SOLE MBR. They leave the trade-name field blank. Accordingly, “Slimshot” should not automatically be treated as the declared business brand simply because it appears in the domain. Nor does the operator’s name establish a peptide-treatment offering. The documented business is a website presenting medical weight-management care, with the operator identified more clearly than the treating professional.
The homepage says a licensed physician provides the weight-management care and states that professional credentials are available through the entity. Those are provider representations, not independently verified credentials. The consulted pages do not identify the treating physician by name, provide license numbers or establish a board-certified specialty. They also do not identify a separate clinical organization responsible for treatment. Asking for those details would clarify who is accountable for the consultation and subsequent clinical decisions.
This distinction matters because a website operator, treating clinician and dispensing pharmacy can have different responsibilities. The documentation here does not complete that responsibility map. A prospective patient can ask for the clinician’s name, professional credentials and applicable state license before the visit, together with the entity named on clinical consent forms. Our explanation of clinician and platform responsibilities offers a way to separate those roles without assuming that every service uses the same organizational structure.
The assessment has a stated purpose, but eligibility remains individualized
The consultation description is more specific than a simple invitation to lose weight. Patients are told they will discuss health history, previous weight-loss attempts and clinical goals. The process also describes physician review of relevant history, lifestyle factors and metabolic-health considerations. Separately, metabolic-health assessments are advertised as reviewing factors that can influence weight, energy, appetite and long-term health. However, the pages do not name particular laboratory tests or establish that testing is included.
Candidacy is said to depend on medical history, current health, goals and the physician’s clinical assessment. The separate terms require users enrolling in a program to be at least 18 and legally capable of entering an agreement. They also state that services are not intended for minors, pregnant or breastfeeding individuals, or people with certain contraindicated medical conditions. That passage does not enumerate those conditions, so it should not be converted into a complete screening checklist.
No provider-specific BMI threshold, mandatory laboratory panel or full contraindication list is established. These omissions do not mean there is no clinical screening; they mean its details cannot be reconstructed from the public pages. Before booking, ask what records are needed, whether outside test results can be used and whether an assessment fee remains payable if the clinician recommends no program. The documented eligibility language supports an evaluation process, not guaranteed admission or a guaranteed prescription.
The documented plan centers on guidance, not an identified drug
The practice describes recommendations shaped around a patient’s needs, health status and sustainable routines. It says a tailored plan may include medical guidance, nutrition education and lifestyle support. Another description emphasizes professional guidance around food, activity, sleep and routines. Those are substantive components of the advertised service, but “may include” is conditional language. It does not establish that every patient receives all of them, that a registered dietitian delivers nutrition services or that they are bundled into one price.
The medication boundary is especially important for readers arriving through a GLP-1 directory. The consulted pages do not identify a drug name, active ingredient, brand, route, formulation or compounded preparation. They therefore do not confirm a GLP-1 program. This is a limit of the available documentation, not proof that the practice never prescribes medication. It would be equally unsupported to infer a specific medication offering from the company’s name or from general references to medical weight loss.
A useful request is a written plan explaining which services are proposed, who performs them and whether any medicine is part of the recommendation. If medication is discussed, the exact product and dispensing arrangements should be established separately. The practice’s lifestyle descriptions cannot fill that information gap. Nor can clinical trial results for particular medicines establish results for this practice, whose reviewed pages do not identify a treatment product or report measured patient outcomes.
Prescribing, pharmacy and shipping responsibilities are not mapped
The public documentation does not show a transition from assessment to a prescription, a named pharmacy or a shipment. There are no established medication prices, dispensing arrangements, shipping charges, refrigeration procedures or delivery timelines. Consequently, there is no basis to describe this practice as offering home-delivered injections, compounded medicine or a particular pharmacy network. These are unanswered operational questions, not demonstrated service failures, and they should remain separate from the consultation services the website actually advertises.
The terms contemplate purchases involving outside providers and explain that additional conditions may apply to particular products or services. That general commercial language does not identify a pharmacy partner or demonstrate that a pharmacy transaction forms part of medical care. If medication is proposed later, ask who receives the prescription, who collects payment and which organization handles dispensing questions. Our guide to the prescription-to-pharmacy handoff explains those distinctions without implying that this practice has a verified dispensing arrangement.
Timing also remains unresolved. The pages establish no clinical-review deadline, prescription-processing interval, dispatch target or arrival estimate. A patient should not interpret appointment availability as a promise of medication access by a particular date. If a prescription becomes part of the plan, request separate explanations of approval, dispensing and delivery, along with a contact route for problems. Until those details are provided, the documentary care pathway ends before a verified pharmacy or shipping handoff.
Follow-up is individualized, while support boundaries need clarification
The website says follow-up visits help evaluate progress and adjust the plan when clinically appropriate. It does not advertise one fixed visit schedule. Instead, the physician is expected to recommend a monitoring cadence based on the plan, progress and clinical needs. That is a clear description of how scheduling is meant to be determined, but it leaves the practical arrangement open: visit frequency, appointment format, between-visit contact and whether follow-up carries a separate charge are not established.
The general terms limit support to the registered account holder. They say account details, medical consultations and billing information cannot be discussed with friends, spouses or other third parties unless required by law or authorized through a signed HIPAA release. This is relevant for anyone relying on a family member to coordinate care. The terms also state that customer support is not a substitute for emergency medical services, so an administrative contact route should not be mistaken for emergency clinical coverage.
There is no clearly completed response-time commitment. The support clause retains the placeholder “[e.g., 24–48] business hours,” making it unsuitable as a dependable turnaround promise. Another clause says profanity, hate speech or personal attacks will end a support session and may lead to permanent account or service suspension without a refund. Before enrollment, clarify the clinical escalation route, routine support availability and how ongoing care would be handled if access to an account or service ended.
Financial and cancellation terms must be obtained for the actual service
The consulted pages do not establish consultation prices, program fees, medication charges, discounts or payment intervals. They also do not specify upfront collection, a minimum commitment or which services would be included in a quoted amount. Insurance acceptance, insurer billing and out-of-network reimbursement arrangements are unresolved. These gaps prevent a meaningful cost comparison and make it important to request an itemized written quote rather than assuming that assessment, follow-up, testing and any treatment share one fee.
The refund language is general rather than medical-program-specific. It says a purchase may or may not provide a refund and that each product, service, event or course will specify its own policy. That does not establish a refund right for an unsuitable consultation or unused care. No specific medical-service renewal, recurring-billing or cancellation procedure is established either. Patients should request the policy governing the exact service they intend to buy, including what happens if they are not accepted for treatment.
The documents also contain inconsistencies that complicate reliance on their wording. Separate terms refer to the “State of United Kingdom” and arbitration in “United States, United States,” while homepage terms refer to the jurisdiction where the entity operates. Other passages describe an educational-only purpose despite the medical-care presentation. These discrepancies warrant a current, completed agreement, not a legal conclusion about enforceability. Our guide to changing plans and stopping payments helps distinguish cancellation, billing termination and refund questions.
Text-message permissions are separate from treatment enrollment
The homepage says SMS notifications can be stopped by replying STOP, followed by a final confirmation, and says opt-out requests are processed within 24 hours. This is a message-preference procedure, not a clinical response deadline. It also does not establish cancellation of treatment, an account, a subscription or a payment obligation. Anyone ending care would need the separate medical-service cancellation instructions rather than relying on a text-message opt-out.
The two privacy descriptions deserve reconciliation. The homepage says promotional content is not sent without specific consent. The separate privacy policy describes opting in to both nonmarketing messages—such as appointment reminders and service notifications—and marketing or promotional texts. Those formulations are not identical. Before providing a number, ask which consent the actual enrollment form requests and whether operational reminders can be selected independently from promotional messages.
The separate policy states that mobile information and SMS opt-in data are not shared with third parties or affiliates for marketing or promotional purposes. It also allows requests to access, correct, update or delete personally identifiable information submitted to the website. These are documented privacy representations, not an independent audit of data handling. A prospective patient should establish the appropriate channel for sensitive medical records rather than assuming an ordinary inquiry form or SMS exchange is the clinical intake system.
Questions & answers
Does NOVA HEALTH PEPTIDES offer semaglutide, tirzepatide or another GLP-1 medicine?
The consulted sources do not confirm that. They describe medical weight-management services without identifying a medication, active ingredient, formulation or route. The company name is not evidence of a peptide or GLP-1 offering. Ask the practice directly for its current service description and, if medication is proposed, the exact product and dispensing pharmacy.
How can I arrange a consultation?
The website publishes +1 941-250-4470 and invites phone or email inquiries about availability and next steps. The email is obscured in the consulted material. Confirm your location can be served, whether the visit is remote or in person, the clinician’s identity and the consultation price. No booking or clinical-review turnaround is established.
Who is eligible for its services?
The terms require adulthood—at least 18—and legal capacity to enter an agreement. They exclude minors, pregnant or breastfeeding individuals and people with certain unspecified contraindicated conditions. The homepage says candidacy depends on history, current health, goals and physician assessment. These statements do not supply a complete eligibility checklist or guarantee acceptance.
What does ongoing care include?
The practice describes progress review and plan adjustments when clinically appropriate, with a monitoring schedule recommended by the physician. Plans may include medical guidance, nutrition education and lifestyle support. The pages do not establish a fixed visit allowance, unlimited messaging or bundled follow-up fees. Ask for the proposed schedule and the responsible clinical contact in writing.
Can I get a refund if I decide not to continue?
No program-specific refund entitlement is established. The general terms say purchases may or may not allow refunds and defer to the policy for the particular service. Obtain that policy before paying, including rules for an assessment that does not lead to treatment. Cancellation and refund eligibility are separate questions; neither should be inferred from the other.
Does replying STOP cancel my care or billing?
The documented STOP procedure cancels SMS notifications, with opt-out processing stated as within 24 hours. It does not establish cancellation of medical care or charges. Ask for a separate service-cancellation process and confirmation of any remaining obligations. Also clarify whether the consent form combines promotional texts with appointment and service messages.
Our assessment
NOVA HEALTH PEPTIDES documents the outline of a physician-led weight-management service: assessment, individualized recommendations, lifestyle guidance and follow-up. That gives prospective patients a basis for an initial inquiry, but not a complete treatment pathway. The consulted sources do not confirm a GLP-1 program, identify the treating physician or establish medication, pharmacy, pricing and cancellation arrangements. Unfinished and inconsistent terms add a separate documentation concern. The useful next step is to request a current service agreement, clinician details, location eligibility, itemized fees and a written follow-up plan. Judge the resulting offer on those specifics rather than the domain or company name.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.